The CMO has reiterated on many occasions that it is likely that Xanamem will be used with other drugs and I believe that is what they are again saying ie low drug drug interaction. It is not that Xanamem will be a therapeutic in its own right for those other opportunities. So it is to be used as an adjunct in those other potential opportunities.
Ann: ACW XanaCIDD depression trial results expected early August, page-8
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.001(4.17%) |
Mkt cap ! $73.62M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.4¢ | $64.83K | 2.646M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 3924751 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 3226651 | 6 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |